Hepatic Encephalopathy Management

Clinical Manifestations

The American Association for the Study of Liver Diseases recommends identifying patients with hepatic encephalopathy grade I and II, characterized by mild to moderate cognitive alterations, requiring early identification and treatment with lactulose as first-line therapy, adjusting the dose to achieve 2-3 soft stools per day 1, 2
Patients with hepatic encephalopathy grade I may exhibit mild alterations in consciousness, subtle changes in personality or behavior, decreased attention, sleep disturbances, irritability or apathy, and difficulty performing complex cognitive tasks 3, 4
Hepatic encephalopathy grade II is characterized by mild disorientation, especially temporal, more pronounced lethargy or apathy, inappropriate behavior, asterixis, dysarthric or slow speech, and evident alterations in psychometric tests 3, 4, 5

The European Association for the Study of the Liver suggests that identifying and correcting precipitating factors is crucial, resolving up to 90% of cases, with common factors including infections, gastrointestinal bleeding, constipation, dehydration, electrolyte disturbances, and sedative medications 1, 2, 3
Lactulose is recommended as first-line treatment, with a dose titrated to achieve 2-3 soft stools per day, and rifaximin as second-line or additional therapy for patients with recurrent episodes despite lactulose use 1, 6, 7

The American College of Gastroenterology recommends that hepatic encephalopathy grade I and II does not usually require ICU admission, unlike grades III and IV, and that the first episode of hepatic encephalopathy should prompt an evaluation for liver transplantation 1, 2
Secondary prophylaxis with lactulose is indicated after the first episode, and rifaximin is recommended as an adjunct to lactulose after recurrent episodes 1, 7
Isolated blood ammonia determination does not provide diagnostic, prognostic, or staging value 3, 8

Failing to seek precipitating factors, which cause 90% of cases, and not titrating the lactulose dose adequately to achieve 2-3 stools per day 1, 2, 3
Confusing hepatic encephalopathy with other causes of altered mental status, and not considering secondary prophylaxis after the first episode 1, 3, 7, 8
Relying exclusively on ammonia levels for diagnosis 3, 8

Patients with grade 0-1 encephalopathy can typically be managed on a medicine ward rather than requiring ICU admission, as recommended by the American Association for the Study of Liver Diseases 9, 10
Avoid sedatives when possible as they can worsen encephalopathy and have delayed clearance in liver failure, according to the American Association for the Study of Liver Diseases 9

Systematically investigate for signs suggestive of hepatic encephalopathy: asterixis, psychomotor slowing, sleep-wake inversion, temporospatial disorientation, as suggested by the European Association for the Study of the Liver 11
Brain CT imaging should be performed to exclude other causes of decreased mental status, though it has limited utility in identifying cerebral edema, as recommended by the American Association for the Study of Liver Diseases 9, 10
Consider using the animal naming test to detect covert (minimal) hepatic encephalopathy, as suggested by the European Association for the Study of the Liver 11

Secondary prophylaxis with lactulose is recommended after the first episode of overt hepatic encephalopathy, according to the European Association for the Study of the Liver 12
Recurrent intractable hepatic encephalopathy, together with liver failure, is an indication for liver transplantation evaluation, as recommended by the European Association for the Study of the Liver 12

Perform frequent mental status checks with transfer to an ICU if level of consciousness declines, as recommended by the American Association for the Study of Liver Diseases 9
If the patient's condition progresses to grade II encephalopathy, transfer to an ICU setting is indicated, according to the American Association for the Study of Liver Diseases 9, 10
Follow closely for metabolic abnormalities including glucose, potassium, magnesium, and phosphate levels, as suggested by the American Association for the Study of Liver Diseases 9

Prophylactic therapy may be discontinued only when precipitating factors are well-controlled, infections treated, variceal bleeding resolved, or liver function/nutritional status significantly improved, as recommended by the European Association for the Study of the Liver 13
Addressing malnutrition present in approximately 75% of patients with hepatic encephalopathy is crucial, and providing moderate hyperalimentation with small, frequent meals throughout the day, including a late-night snack, is recommended by the American Association for the Study of Liver Diseases 13
Multivitamin supplementation is generally recommended for patients with hepatic encephalopathy, according to the American Association for the Study of Liver Diseases 13